SIGN UP

Vas Narasimhan, Novartis CEO (Simon Dawson/Bloomberg via Getty Images)

November 18, 2021 09:12 AM EST

Are the stars lining up for a major M&A deal at Novartis?

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE

ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Takeda announces handful of pipeline cuts in effort to ‘pivot resources’

GSK awaits Nucala decision after FDA target date passes

AI-focused biotech insitro cuts 22% of staff, citing 'tumultuous market'

'Find a way, or make one': How two scientists hope to revitalize CRISPR's rare disease crisis

AstraZeneca loses appeals court fight over IRA drug price negotiations

sponsored

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges